TRADES
Latest Trades
197
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 8 Dec 2022 Sell SGFY SIGNIFY HEALTH INC 93 0.0001
ARKG 7 Dec 2022 Sell SGFY SIGNIFY HEALTH INC 452 0.0006
ARKG 6 Dec 2022 Sell SGFY SIGNIFY HEALTH INC 7,285 0.0096
ARKG 1 Dec 2022 Sell SGFY SIGNIFY HEALTH INC 15,342 0.0193
ARKG 25 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 17,500 0.0221
ARKG 22 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 5,000 0.0062
ARKG 21 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 15,000 0.0183
ARKG 17 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 80,000 0.0945
ARKG 16 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 64,502 0.0737
ARKG 15 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 84,866 0.0972
ARKG 14 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 25,000 0.0281
ARKG 11 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 15,196 0.0183
ARKG 8 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 25,383 0.0336
ARKG 7 Nov 2022 SELL SGFY SIGNIFY HEALTH INC 50,000 0.0641
ARKG 4 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 25,000 0.0318
ARKG 3 Nov 2022 Sell SGFY SIGNIFY HEALTH INC 25,000 0.0317
ARKG 28 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 25,000 0.0317
ARKG 27 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 35,000 0.0436
ARKG 25 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 50,860 0.0683
ARKG 24 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 175,000 0.2319
ARKG 20 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 286,151 0.3885
ARKG 17 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 77,716 0.1058
ARKG 14 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 61,493 0.0801
ARKG 13 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 105,000 0.1351
ARKG 12 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 212,245 0.2734
ARKG 11 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 277,290 0.3520
ARKG 10 Oct 2022 Sell SGFY SIGNIFY HEALTH INC 208,443 0.2544
ARKK 30 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 412 0.0002
ARKG 29 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 19,877 0.0236
ARKK 29 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 14,877 0.0056
ARKG 28 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 58,077 0.0731
ARKK 28 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 38,669 0.0152
ARKG 26 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 977,975 1.2303
ARKK 26 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 63,089 0.0252
ARKG 23 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 241,547 0.2945
ARKK 23 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 51,495 0.0201
ARKG 22 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 330,918 0.3926
ARKK 22 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 158,979 0.0597
ARKG 21 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 22,479 0.0258
ARKK 21 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 34,558 0.0129
ARKG 20 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 432,107 0.4887
ARKK 20 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 670,690 0.2447
ARKG 19 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 254,790 0.2820
ARKK 19 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 401,083 0.1455
ARKG 16 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 292,097 0.3055
ARKK 16 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 882,513 0.3047
ARKG 14 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 327,885 0.3546
ARKK 14 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 502,977 0.1760
ARKG 13 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 600,410 0.6159
ARKK 13 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 946,649 0.3106
ARKK 8 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 518,170 0.1936
ARKG 7 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 37,529 0.0432
ARKK 7 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 1,090,563 0.4164
ARKG 6 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 411,903 0.4657
ARKK 6 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 1,246,014 0.4655
ARKG 2 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 108,550 0.1184
ARKK 2 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 265,932 0.0964
ARKG 1 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 132,906 0.1411
ARKK 1 Sep 2022 Sell SGFY SIGNIFY HEALTH INC 322,683 0.1139
ARKG 31 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 98,874 0.1045
ARKK 31 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 239,151 0.0838
ARKG 30 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 65,684 0.0680
ARKK 30 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 157,832 0.0537
ARKK 29 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 64,106 0.0215
ARKG 25 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 86,358 0.0858
ARKK 25 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 223,257 0.0745
ARKG 24 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 46,614 0.0476
ARKK 24 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 120,977 0.0423
ARKG 23 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 267,226 0.2732
ARKK 23 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 687,161 0.2348
ARKG 22 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 642,230 0.6560
ARKK 22 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 1,069,686 0.3547
ARKG 19 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 38,803 0.0288
ARKK 19 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 119,768 0.0282
ARKG 18 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 76,704 0.0563
ARKK 18 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 236,507 0.0549
ARKG 17 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 43,532 0.0306
ARKK 17 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 95,512 0.0212
ARKG 15 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 44,595 0.0317
ARKK 15 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 142,253 0.0320
ARKK 12 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 410,765 0.0956
ARKK 11 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 132,805 0.0317
ARKK 10 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 179,906 0.0430
ARKK 9 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 429,233 0.0947
ARKK 8 Aug 2022 Sell SGFY SIGNIFY HEALTH INC 994,801 0.2214
ARKG 24 Jan 2022 Buy SGFY SIGNIFY HEALTH INC 51,689 0.0160
ARKG 21 Jan 2022 Buy SGFY SIGNIFY HEALTH INC 164,710 0.0526
ARKG 20 Jan 2022 Buy SGFY SIGNIFY HEALTH INC 39,424 0.0127
ARKG 19 Jan 2022 Buy SGFY SIGNIFY HEALTH INC 39,992 0.0124
ARKK 5 Jan 2022 Buy SGFY SIGNIFY HEALTH INC 188,200 0.0160
ARKG 4 Jan 2022 Buy SGFY SIGNIFY HEALTH INC 51,500 0.0141
ARKG 3 Jan 2022 Buy SGFY SIGNIFY HEALTH INC 13,200 0.0039
ARKG 31 Dec 2021 Buy SGFY SIGNIFY HEALTH INC 23,900 0.0067
ARKG 30 Dec 2021 Buy SGFY SIGNIFY HEALTH INC 100 0.0000
ARKG 29 Dec 2021 Buy SGFY SIGNIFY HEALTH INC 105,770 0.0279
ARKK 28 Dec 2021 Buy SGFY SIGNIFY HEALTH INC 20,000 0.0016
ARKK 27 Dec 2021 Sell SGFY SIGNIFY HEALTH INC 20,321 0.0017
ARKG 7 Dec 2021 Buy SGFY SIGNIFY HEALTH INC 160,234 0.0474
ARKK 7 Dec 2021 Buy SGFY SIGNIFY HEALTH INC 313,766 0.0289
ARKK 6 Dec 2021 Buy SGFY SIGNIFY HEALTH INC 20,402 0.0000
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.